Novartis Meningitis Blockbuster Strategy Key To Firm’s Vaccine Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis plans to submit ACWY meningitis BLA in the second half, putting Menveo on track for approval in 2009.